PureTech Health plc (LON:PRTC - Get Free Report)'s share price traded up 14.6% during mid-day trading on Saturday . The stock traded as high as GBX 118 ($1.57) and last traded at GBX 118 ($1.57). 1,623,564 shares traded hands during mid-day trading, an increase of 54% from the average session volume of 1,056,594 shares. The stock had previously closed at GBX 103 ($1.37).
PureTech Health Trading Up 0.8 %
The firm's 50 day moving average is GBX 133.04 and its 200 day moving average is GBX 147.21. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51. The company has a market capitalization of £370.67 million, a PE ratio of -5.06 and a beta of 1.02.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Further Reading
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
